Determinants of physical activity level in pediatric oncological patients treated with cardiotoxic therapy - a study protocol
- PMID: 40320516
- PMCID: PMC12051312
- DOI: 10.1186/s12887-025-05714-5
Determinants of physical activity level in pediatric oncological patients treated with cardiotoxic therapy - a study protocol
Abstract
Background: Childhood cancer and its therapy, especially that involving potentially cardiotoxic cancer treatment, can structurally affect muscle strength and heart function, and therefore may result in lowered physical activity (PA). This study protocol aims to find the significant determinants of PA levels in pediatric oncological patients 1-5 years after heart-toxic chemotherapy and/or radiation of the heart region.
Methods: The study group will include children 1-5 years after completing cancer therapy involving cardiotoxicity risk factors. The primary outcome of interest is the PA measured with an ActiGraph GT3X Accelerometer for 14 consecutive days and the assessment of WHO pediatric age-adjusted PA norms achievement. Assessed PA levels will be evaluated according to the possible determinants of PA: disease/treatment related risk factors, treatment complications, possible complications after the treatment, cardiac function with echocardiography including 2D and 3D strain imaging, physical function and muscle strength in ALPHA (Assessing Levels of Physical Activity) health-related fitness test battery and exercise capacity in cardiopulmonary exercise testing. The self-efficacy and motivation to PA, quality of life (QoL), lifestyle, socio-demographic, and anthropogenic factors as well as knowledge about the positive impact of PA will be evaluated with original and validated questionnaires. The PA determinants of the study group will be compared to the results of the control group of children in the same follow-up period (> 1 year < 5 years) after completing cancer therapy without cardiotoxic methods.
Discussion: The results may contribute to the development of future recommendations on prophylactic and therapeutic approaches, as well as proper lifestyle recommendations for children in long-term follow-up after cardiotoxic cancer therapy. The determinants will be used to develop targeted exercise prescriptions and exercise programs.
Trial registration: NCT06256068.
Keywords: Cardiotoxicity; Childhood cancer; Exercise capacity; Pediatric oncology; Physical activity.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study will be conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures involving patients are approved by the local Ethic Examining Committee of Human Research of the Medical University of Warsaw (Decision of Approval: KB/54/A2023). Informed consent will be obtained from all subjects involved in the study. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol.BMC Cardiovasc Disord. 2021 Apr 7;21(1):165. doi: 10.1186/s12872-021-01970-2. BMC Cardiovasc Disord. 2021. PMID: 33827450 Free PMC article.
-
Cardiotoxicity screening of long-term, breast cancer survivors-The CAROLE (Cardiac-Related Oncologic Late Effects) Study.Cancer Med. 2021 Aug;10(15):5051-5061. doi: 10.1002/cam4.4037. Epub 2021 Jul 10. Cancer Med. 2021. PMID: 34245128 Free PMC article.
-
Comparison of Students' Physical Activity at Different Times and Establishment of a Regression Model for Smart Fitness Trackers.Sensors (Basel). 2025 Mar 11;25(6):1726. doi: 10.3390/s25061726. Sensors (Basel). 2025. PMID: 40292814 Free PMC article.
-
Treatment-related cardiotoxicity in survivors of childhood cancer.Nat Rev Clin Oncol. 2013 Dec;10(12):697-710. doi: 10.1038/nrclinonc.2013.195. Epub 2013 Oct 29. Nat Rev Clin Oncol. 2013. PMID: 24165948 Review.
-
[Cardiotoxicity as undesired side effect in the treatment of breast cancer].Postepy Hig Med Dosw (Online). 2014 May 8;68:483-97. doi: 10.5604/17322693.1101581. Postepy Hig Med Dosw (Online). 2014. PMID: 24864100 Review. Polish.
References
-
- Morris JN, Roder D, Turnbull D, Hunkin H. The impact of cancer on early childhood development: a linked data study. J Pediatr Psychol. 2021;46(1):49–58. - PubMed
-
- Swerdlow SHCE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J. WHO classification of tumours of haematopoietic and lymphoid tissues. WHO classification of tumours. Revised 4th Edition, Volume 2. Lyon: International Agency for Research on Cancer (IARC); 2017.
-
- Li HC, Lopez V, Joyce Chung OK, Ho KY, Chiu SY. The impact of cancer on the physical, psychological and social well-being of childhood cancer survivors. Eur J Oncol Nurs. 2013;17(2):214–9. - PubMed
-
- Murphy AJ, White M, Elliott SA, Lockwood L, Hallahan A, Davies PS. Body composition of children with cancer during treatment and in survivorship. Am J Clin Nutr. 2015;102(4):891–6. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical